Steve Rees

Steve Rees is Vice-President of Discovery Biology at AstraZeneca with global responsibility for early discovery capabilities including functional genomics, reagent generation and assay development and cell and gene therapies. Previously Steve led the Screening Sciences and Sample Management department with accountability for Compound Management, Hit Discovery and Lead Optimisation biology. Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles. Steve has led multiple international collaborations, has authored >65 scientific papers and has spoken at many international symposia. He has served as Chair of the European council of the Society of Laboratory Automation and Screening, Chair of the European Laboratory Research and Innovation Group and is Industry Trustee of the British Pharmacological Society. Steve is a member of the Scientific Advisory Board for WCAIR at the University of Dundee, EU-OPENSCREEN and the Centre for Membrane Protein Receptor Research at the Universities of Birmingham and Nottingham.